NF-κB gene mutations are known to be the most prevalent in MM among all human cancers [14,15,17,24,25], and plays a pivotal role in anti-cancer therapy and drug resistance [26,27,28,29]. This evidence concerns the gene NFKB1 and Miyoshi myopathy.